Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 3Weight Loss 2Neoplasms 2Cachexia 2Body Weight 2Anorexia 2Recurrence 1Pancreatic Neoplasms 1Menorrhagia 1Lung Neoplasms 1Leiomyoma 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6relugolix 5Norethindrone Acetate 5vilaprisan 4Uterine Myomectomy 3linzagolix 2Uterine Artery Embolization 2ulipristal 1Radiofrequency Ablation 1Progesterone 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Electrocoagulation 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Menorrhagia × Megestrol Acetate × Clear all
NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
120 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡